Shoko Yoshida

4PUBLICATIONS
11CO-AUTHORS
Toxicology (incl. clinical toxicology)Cardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Other Asian languages (excl. South-East Asian)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 21, 2025
Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data.

Katsuyoshi Matsuoka, Satoshi Motoya, Takayuki Yamamoto

|Dec 12, 2024
Identifying Risk Factors of Major Adverse Cardiac Events in Patients With Ulcerative Colitis: A Retrospective Japanese Claims Data Analysis.

Tomohisa Takagi, Linghua Xu, Masato Hoshi

|Nov 14, 2023
Changes in surgery rates among hospitalized patients with inflammatory bowel disease in Japan from 2015 to 2019: A nationwide administrative database analysis.

Shoko Yoshida, Shinobu Imai, Kiyohide Fushimi

|Jun 23, 2022
Safety and efficacy of long-term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open.

Katsuyoshi Matsuoka, Tadakazu Hisamatsu, Hyo Jong Kim

Pageof 1

Frequent Collaborators

2 joint publications

Masato Hoshi

1 joint publications

Katsuyoshi Matsuoka

1 joint publications

Tadakazu Hisamatsu

1 joint publications

Hyo Jong Kim